Online training during Covid restrictions - our programes continue this spring in online webinar format

The New EU (European Union) Animal Health Legislation for Veterinary Medicinal Products Training Course

The programme will offer a comprehensive introduction to the new EU Regulation (2019/6) and will address the changes and implications to the industry including marketing authorisations, submissions and dossiers.

*INCLUDES: Interactive discussion sessions*

2-3 Nov 2021

& 4-5 Nov 2021

Book now


Course overview

The new EU Regulation (2019/6) on Veterinary Medicinal Products will be applicable for all EU countries from 28 January 2022 and will have massive implications for all animal health companies operating in, or wanting to operate in the EU. This seminar will provide essential insight into these revolutionary changes and enable participants to plan their regulatory strategies going forward.

The programme will offer a comprehensive introduction to the legislative changes and will address the new issues, marketing authorisation (MA) submissions and dossiers. Data protection and routes to market will be discussed, as will post-marketing measures and variations. The implications for supply and use, off-label use and inspection controls will also be covered.

This is a must-attend seminar for all animal health professionals.

Benefits of attending:

  • Be prepared for the revolutionary changes to the EU legislation
  • Gain essential guidance on the implications of the changes
  • Understand how this will affect you and your company
  • Hear the implications on variations
  • Be aware of the opportunities the changes will create
  • Comply with data protection and routes to market
  • Understand the post-market measures
  • Plan for the impact on supply and use

Who should attend?

This seminar will be beneficial to all those working in the animal health industry including:

  • Regulatory affairs managers
  • R&D associates
  • Manufacturing professionals
  • Sales and marketing managers
  • Directors and CEOs
  • Personnel who are new to the animal health industry and all those needing an overview of the new legislation


Julian Braidwood (More...)

Julian Braidwood qualified as a Veterinary Surgeon and worked in mixed practices before spending fifteen years in R&D and Regulatory departments of five leading Animal Health companies. Julian has managed clinical trials and regulatory groups, experimental facilities, laboratories, and worked internationally in many countries. Having become an R&D Director within the industry, he co-founded Triveritas in 2,000 which grew rapidly internationally and became part of knoell in 2021. knoell is one of the leading service providers for worldwide registration and regulatory compliance in crop protection, crop nutrition, chemicals, cosmetics, animal health products, and medical devices. The knoell Group employs almost 600 people worldwide in more than 14 countries.

knoell is the only knowledge-based animal health consultancy and clinical studies specialist with its own technical staff based on three continents: North America, Europe, and Asia. The animal health team offers a full portfolio of services, including start-to-finish product development and ad hoc services – in all domesticated species for pharmaceuticals and biologicals, feed additives, novel, generic and borderline products.

Book now

Book now

2-3 Nov 2021
Live webinar
2-3 Nov 2021
Live webinar
GBP 1,199 999
EUR 1,719 1,439
USD 1,942 1,630
Until 21 Sep*
Enrol now
to attend
Live webinar
4-5 Nov 2021
Face-to-face, (venue not yet confirmed)
4-5 Nov 2021
(venue not yet confirmed)
GBP 1,399 1,199
EUR 1,959 1,679
USD 2,182 1,870
Until 23 Sep*
Enrol now
to attend
(venue not yet confirmed)
  • 2 days classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Continuing professional development

This course qualifies for 12 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

Previous customers include...

  • Bela-Pharm GmbH & Co. KG
  • Benchmark Vaccines Limited
  • Boehrigner Ingelheim VRC GmbH & Co. KG
  • Boehringer Ingelheim Animal Health Nordics A/S
  • Boehringer Inghelheim Animal Health Netherlands B.V.
  • Chef du Monde
  • Cross Vetpharm Group UK Ltd
  • DADA Consultancy BV
  • Delaval NV
  • Elanco Animal Health
  • Elanco Deutschland GmbH
  • European Medicines Agency
  • FATRO S.p.A.
  • Hifarmax, Produtos e Serviços Veterinários, Lda.
  • Nutreco Nederland BV
  • Regivet BV
  • Research and Markets
  • Vana GmbH
  • Vetcare Oy
  • Vetoquinol Biowet
  • Zoetis Deutschland GmbH

Content = good however some of the points were of little relevance to me.
Presentation = excellent. Very clear slides and the speed of delivery was perfect.
Speaker = excellent. Very knowledgeable and happy to discuss topics in depth if required

Rodney Cartmill, Head of Regulatory Affairs - New Products, Norbrook Laboratories Ltd, Nov 20

An interesting, informative and interactive two-day course which provided a clear overview and explanation of the most important changes that we can expect as a result of the 2019/6 Legislation. It is not easy to keep the audience interested while explaining a new law but Julian managed to do this excellently.

Kitty Ruigrok, DVM, Regivet BV, Dec 19

The main themes of the new Regulation were presented in a precise but detailed manner and this, coupled with the extensive knowledge and sympathetic manner of the speaker, make the course something special.

Heike Luckow, Regulatory Affairs, Bela-Pharm GmbH & Co. KG, Dec 19

Julian was a fantastic presenter, with excellent examples of real-life scenarios making a potentially dry course thoroughly enjoyable.

Jennifer Hynes, Quality Manager, Benchmark Vaccines Limited, Mar 19